This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

The place of neuroimaging

Authoring team

  • neuroimaging is not routinely indicated in every case of childhood epilepsy e.g. in those with a well-defined benign syndrome such as benign Rolandic epilepsy of childhood. Also neuroimaging is not routinely indicated in children with a definite diagnosis of an idiopathic generalised epilepsy syndrome e.g. juvenile myoclonic epilepsy, typical absence epilepsy
  • neuroimaging is always indicated if the child has evidence of:
    • developmental regression, a neurological deficit, or a neurocutaneous syndrome (e.g. neurofibromatosis, tuberose sclerosis)
    • a partial onset of seizures (simple and/or complex)
    • myoclonic seizures (other than juvenile myoclonic epilepsy)
    • infantile spasms
    • seizures refractory to treatment, unclassifiable seizures
    • if there is unexplained loss of previously good seizure control

Also, a child who has previously had a normal brain scan, but whose epilepsy remains poorly controlled, should probably have repeat imaging, ideally 12-18 months after previous 'normal' scan .

Magnetic resonance imaging is the recommended neuroimaging technique. It is superior to computerised tomography in terms of sensitivity and specificity.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.